Status:
COMPLETED
Dissociation CBT Studies
Lead Sponsor:
University of Birmingham
Conditions:
Dissociation
Depersonalization
Eligibility:
All Genders
16-80 years
Phase:
NA
Brief Summary
Dissociation involves distressing feelings of unreality and disconnection. Evidence suggests it is particularly common amongst people with existing mental health difficulties, where it has been linked...
Detailed Description
1. What is dissociation? "I was in a totally different world; it was going on all around me. I thought that I might have died and was in hell, and I was thinking maybe that's what it was." -- "Mar...
Eligibility Criteria
Inclusion
- Aged between 16 years to 80 years;
- Outpatient of UK mental health services (at the time of referral to the study);
- Experiencing significant levels of 'felt sense of anomaly'-type dissociation (defined as a score within the 'moderately severe' or 'severe' range on the ČEFSA-14 (i.e., 39 or above); Černis et al., in prep.);
- Want help to improve their dissociative experiences;
- Willing and able to give consent for participation in the study;
- Available to undertake the baseline assessment in the indicated week;
- Available to undertake the therapy sessions within the indicated therapy 'window'.
Exclusion
- The participant may not enter the study if ANY of the following apply:
- Diagnosis of an Axis II ("personality") disorder;
- Primary diagnosis of alcohol/substance dependency, organic syndrome, or learning disability;
- Presence of risk issues that would be a clinical priority above managing dissociative symptoms (e.g., moderate to severe self-harm; active suicidal behaviour; etc.);
- Current engagement in any other individual psychological therapy (or psychological therapy due to begin within the participation window for this study).
- A participant may also not enter the study if there is another factor (i.e., with higher clinical priority), which, in the judgement of the investigator, would preclude the participant from providing informed consent or from safely engaging with the study procedures.
Key Trial Info
Start Date :
September 20 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 12 2025
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT06054009
Start Date
September 20 2023
End Date
March 12 2025
Last Update
July 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Birmingham Womens and Childrens NHS Foundation Trust
Birmingham, United Kingdom